Zobrazeno 1 - 10
of 12
pro vyhledávání: '"N. Lapkina"'
Autor:
E. Y. Pogozheva, V. N. Amirjanova, T. Yu. Grineva, A. A. Baranov, A. M. Lila, E. L. Nasonov, N. Lapkina, R. R. Samigullina, Vadim I. Mazurov, O. N. Anoshenkova, A. E. Karateev
Publikováno v:
Научно-практическая ревматология, Vol 59, Iss 5, Pp 571-577 (2021)
Upadacitinib (UPA), a JAK inhibitor, is a new therapeutic option that allows patients with insufficient response to therapy with basic anti-inflammatory drugs (DMARDs) or genetically engineered biological drugs (GEBDs) to achieve the goals of therapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12b21c28a6c6be074c1f967446a44cd7
https://rsp.mediar-press.net/rsp/article/view/3077
https://rsp.mediar-press.net/rsp/article/view/3077
Autor:
N. Lapkina, A. Baranov, N. Levshin, N. Abaitova, A. Avdeeva, E. Leontieva, A. Artyuhov, E. Nasonov
Publikováno v:
Annals of the Rheumatic Diseases. 81:607.2-608
BackgroundPathogenesis of RA includes numerous interactions of genetic and acquired defects in normal immunoregulation, one is disbalance of pro- and anti-inflammatory cytokines production. Basic treatment conception in RA is «treat-to-target», inc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1182822f703c53b8ddf297ea412e2f0f
https://doi.org/10.1136/annrheumdis-2022-eular.354
https://doi.org/10.1136/annrheumdis-2022-eular.354
Autor:
Alexander Lila, Nasonov El, E. Gaydukova, L. Solodovnikova, E. Kryukova, N. Lapkina, V. Mazurov, O. Semagina, Diana Abdulganieva, S A Lapshina, Inna Gaydukova, D. Kretchikova, I. Vinogradova, L. Myasoutova, O. Epifanova
Publikováno v:
Annals of the Rheumatic Diseases. 79:1470-1471
Background:Currently it is unclear whether combination of tofacitinib (tofa) with methotrexate (Mtx) more effective and safe than tofa in monotherapy.Objectives:To compare efficacy and safety of tofacitinib monotherapy with combination of tofa and mt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::13ee54e17f37759a9fb86c0bc5f9eb50
https://doi.org/10.1136/annrheumdis-2020-eular.4773
https://doi.org/10.1136/annrheumdis-2020-eular.4773
Autor:
Inna Gaydukova, A Misiyuk, V. Mazurov, E. Zhilyaev, A. R. Babaeva, Valentina Sorotskaya, Oxana Fomina, E. Vasilenko, Vyacheslav Poncratov, N. Lapkina, A Pavlova, Galina Lukina, Evgeny Nasonov
Publikováno v:
Poster Presentations.
Background: In previous studies tofacitinib (TF) had demonstrated efficacy of two dosages (10 and 20 mg/day) in patients with rheumatoid arthritis (RA). However, the expected results of switching of TF’ dosages are unknown. Objectives: The aim of t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8e26213d34a3cb763c205fde7a5b048c
https://doi.org/10.1136/annrheumdis-2019-eular.6265
https://doi.org/10.1136/annrheumdis-2019-eular.6265
Autor:
N. Lapkina, Ruzana Samigullina, E. Kalinina, Iuliia Grabovetskaya, A Misiyuk, Inna Gaydukova, I. M. Marusenko, Diana Abdulganieva, Natalya Yudina, Larisa Knyazeva, E. Zhilyaev, V. Mazurov, Irina Bondareva, E. Vasilenko, Ilia Smitienko, Galina Lukina, Evgeny Nasonov
Publikováno v:
Poster Presentations.
Background: Tofacitinib (TF) is an oral Janus Kinase inhibitor for the treatment of rheumatoid arthritis (RA). Objectives: To evaluate the one-year effectiveness of tofacitinib as first-line therapy in RA conventional synthetic (cs) DMARDs non-respon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::86091315fd15c3eb386723c0d3a9b98c
https://doi.org/10.1136/annrheumdis-2019-eular.5986
https://doi.org/10.1136/annrheumdis-2019-eular.5986
Autor:
R. Samigullina, N. Kiryukhina, T. Salnikova, T. Rasevich, Nasonov El, E. Kalinina, I. Semizarova, I. Bashkova, D. Kretchikova, D. Bobrikova, I. Vinogradova, V. Sorotskaya, E. Koltsova, A. Dyo, I. Shchendrigin, O. Semagina, A. Dadalova, M. Semchenkova, D. Murtazalieva, Alexander Lila, V. Mazurov, D. Chakieva, A. Davydova, I. Shafieva, A. Baranov, N. Lapkina, I. M. Marusenko, I. Kushnir, A. Karateev
Publikováno v:
Annals of the Rheumatic Diseases. 80:1095.3-1096
Background:JAK inhibitors block intracellular signaling pathways responsible for the synthesis of cytokines and mediators involved in the development of chronic pain and central sensitization (CS). This determines a very rapid clinical response to JA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::77f9af1890928d01dac7b7df61f2fca8
https://doi.org/10.1136/annrheumdis-2021-eular.2902
https://doi.org/10.1136/annrheumdis-2021-eular.2902
Autor:
O. Fomina, Nasonov El, A. R. Babaeva, A. S. Avdeeva, N. Lapkina, V. Sorotskaya, A Misiyuk, Alexander Lila, A. Satybaldyev
Publikováno v:
Annals of the Rheumatic Diseases. 79:1462.3-1463
Objectives:To evaluate the efficacy of tofacitinib therapy (TOFA) in biologic naive and had prior biologic use history patients with rheumatoid arthritis (RA) according to OREL registerMethods:Were analyzed the data from Russian national register of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3c144f94053608a73a832db5379fce33
https://doi.org/10.1136/annrheumdis-2020-eular.3052
https://doi.org/10.1136/annrheumdis-2020-eular.3052
Autor:
Alexander Lila, D. Chakieva, V. Mazurov, A. Karateev, V N Amirdzhanova, O. Semagina, I. M. Marusenko, T. Salnikova, M. Semchenkova, Nasonov El, E. Pogozheva, E. Filatova, N. Lapkina, Galina Lukina, R. Samigullina
Publikováno v:
Annals of the Rheumatic Diseases. 79:327.3-327
Background:The presence of central sensitization (CS) significantly burdens the course of rheumatoid arthritis (RA). JAK inhibitors block intracellular signal pathways including the ones responsible for synthesis of mediators and cytokines causing pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::01898f27910df76e52aa317c23909fab
https://doi.org/10.1136/annrheumdis-2020-eular.4029
https://doi.org/10.1136/annrheumdis-2020-eular.4029
Autor:
N. R. Arkhipova, L. N. Lapkina
Publikováno v:
Russian Journal of Ecology. 31:336-340
The tolerance of annelids (11 oligochaete and 13 leech species) to several organophosphate pesticides, polychloropinene, phenol, and copper sulfate was compared in an acute experiment. The dependence of pesticide resistance on specific biological and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dedf3224bf07abc82d2b8c6732a24d90
https://doi.org/10.1007/bf02828448
https://doi.org/10.1007/bf02828448
Autor:
E. L. Luchikhina, N. Chichasova, G. Gafurova, D. Chakieva, L. Bogoderova, R. Mukhina, Diana Abdulganieva, R. Samigullin, D.E. Karateev, M. Bilinskaya, N. Lapkina, A. Satybaldyev, M. Nikolenko, M. Dmitrieva, Galina Lukina, V. Sorotskaya, E. Nassonov, Mazurov Vi
Publikováno v:
Annals of the Rheumatic Diseases. 75:1002.2-1002
Background Russian register of patients with inflammatory arthritis started in 2012 as a register of RA (“All-Russian register of Rheumatoid Artritis”- ARRA) now transformed into “Observational REgister of arthritis in cLinical practice” (ORE
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::29c94cad08b339802654ef9ac2950124
https://doi.org/10.1136/annrheumdis-2016-eular.4382
https://doi.org/10.1136/annrheumdis-2016-eular.4382